November 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering, especially in North America and Asia Pacific. Used for DNA/RNA cleavage in research and therapy, th...
November 01, 2025
Projections indicate that, the global gene synthesis service market will increase from USD 681.53 million in 2024 to USD 3138.64 million by 2034, experiencing a CAGR of 16.5% over the next 10 years. The rising incidences of chronic disorders, increasing demand for genomics, and growing research & development drive the market....
November 01, 2025
The sterile antimicrobial gel market dominated by silver dressings, is driven by demand for chronic wound care, especially for ulcers. Hospitals lead end-user adoption due to advanced wound care technologies, while public health concerns boost demand for chronic wound solutions, supporting market growth....
November 01, 2025
Core clinical molecular diagnostics applies molecular biology techniques to study diseases like cancer and infections, focusing on patient care. With the aging population increasing chronic disorders, the demand for biomarker analysis grows. Advancements in genomics and proteomics, along with a push for personalized medicine, further drive the mark...
November 01, 2025
Based on market forecasts, the global long read sequencing market, projected at USD 0.78 billion in 2024, is expected to reach USD 11.6 billion by 2034, growing at a CAGR of 30.96% over the forecast period. The rising incidences of genetic disorders, growing research and development, and increasing demand for personalized medicines drive the market...
November 01, 2025
Based on market forecasts, the global DNA sequencing market, projected at USD 15.11 billion in 2024, is expected to reach USD 107.63 billion by 2034, growing at a CAGR of 21.69% over the forecast period. The increasing demand for genomics research, technological advancements, and increasing investments potentiate the market....
November 01, 2025
Bioinformatics leverages computational tools to analyze and interpret biological data, aiding in gene expression, protein regulation, and molecular biology evolution. Advances in genomics, drug discovery, and government support for omics research are driving market growth. Recent innovations include WHO’s 2024 workshop on genomic surveillance...
November 01, 2025
Projections indicate that, the global synthetic biology market will increase from USD 20.49 billion in 2024 to USD 191.48 billion by 2034, experiencing a CAGR of 25.04% over the next 10 years. The rising incidences of chronic disorders, technological advancements, and growing research and development drive the market....
November 01, 2025
DNA diagnostics involve testing genes or chromosomes to detect genetic conditions or predict disease risks. It's used in healthcare, research, biotechnology, and forensics for purposes like newborn screening, genetic counseling, and personalized treatments. Market growth is driven by rising genetic disorders and personalized medicine....
November 01, 2025
Market insights predict the global next generation sequencing industry will increase from USD 10.27 billion in 2024 to USD 73.47 billion by 2034, achieving a CAGR of 21.74%. The NGS market is strongly growing because NGS is needed in disease diagnosis, disease analysis, developing new treatment options, developing gene & cell therapies, etc....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com